Drug class
Narcotic analgesic
Pharmacology
Acts on the CNS by binding with opioid receptors, altering processes affecting pain perception & emotional response to pain.
It also combines to cause respiratory depression, vasodilation, decreases in gag reflex & slows AV node conduction.
Metabolism
By the liver, kidneys & lungs
Indications
*is the preferred narcotic agent except under the following circumstances: • allergy and/or adverse drug reaction • haemodynamic instability • known/suspected kidney disease • when NAS narcotic admin is preferred • suspected ACS
Contraindications
* Kidney disease (renal failure)
Precautions
Side effects
Presentation
10mg/1ml amp
Routes
Onset
Duration
SUBCUT / IM / IV
O: IM 5-10mins - peak 20-30min
IV 2-5mins - peak 20mins
D: 1-2hrs
Special notes
Adult dosages
** CONSULT - SUBCUT for significant pain
• Significant pain
• Autonomic dysreflexia (SBP >160)
▪︎≥70yrs
• IM 2.5-5mg, repeated at up to 5mg every 10mins, total max dose 10mg (or MME)
• IV 2.5mg, repeated at up to 2.5mg every 5mins, total max dose 10mg (or MME)
▪︎ <70yrs
• IM 2.5-10mg, repeated at up to 5mg every 10mins, total max dose 20mg (or MME)
• IV 2.5-5mg, repeated at up to 5mg every 5mins, total max dose 20mg (or MME)
Paediatric dosages
• Significant pain
• Autonomic dysreflexia (SBP >160)
≥ 1yr
▪︎IM
100-200mcg/kg, single max dose 5mg
Total max dose 200mcg/kg (or MME)
▪︎IV
100mcg/kg, single max dose 2.5mg
Repeated @ 50mcg/kg (max 2.5mg) at 5min intervals
Total max dose 200mcg/kg (or MME)